Crohn's Disease

Stelara Shines in Three Year Crohn's Disease Study
CP Wire
Wed, 10/24/18 - 02:43 pm
Janssen
JNJ
Stelara
Crohn's Disease
clinical trials
Stelara Shines in Three Year Crohn's Disease Study
Wed, 10/24/18 - 10:05 am
Jannsen
JNJ
Stelara
Crohn's Disease
Arena 3 for 3 as Crohn’s drug meets proof-of-concept test
Fierce Biotech
Tue, 09/25/18 - 10:01 am
Arena Pharmaceuticals
olorinab
Crohn's Disease
RedHill’s RHB-104 hits primary endpoint in Crohn’s phase 3
Fierce Biotech
Mon, 07/30/18 - 11:23 am
Redhill Biopharma
clinical trials
Crohn's Disease
RHB-104
Johnson & Johnson, looking for its Tremfya niche, starts up new trial program in Crohn's
Fierce Pharma
Wed, 07/11/18 - 11:35 am
JNJ
Tremfya
MorphoSys
Janssen
Crohn's Disease
clinical trials
AbbVie Presents New Data on Upadacitinib for Crohn's Disease
Yahoo/Zacks.com
Mon, 02/19/18 - 04:18 pm
AbbVie
Upadacitinib
Crohn's Disease
J&J strikes potential $1B JAK inhibitor deal with Theravance
Biopharma Dive
Wed, 02/7/18 - 10:06 am
JNJ
JAK inhibitors
Theravance
TD-1473
drug development
Crohn's Disease
ulcerative colitis
Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval
Yahoo/Reuters
Thu, 12/14/17 - 09:18 am
Pfizer
biosimilars
JNJ
Remicade
Ifixi
rheumatoid arthritis
Crohn's Disease
Price Hikes Insulate Celgene From a Failure
Motley Fool
Wed, 10/25/17 - 10:41 pm
Celgene
drug pricing
GED-301
Crohn's Disease
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
Thu, 09/21/17 - 08:49 am
JNJ
Provention Bio
IBD
inflammatory bowel disease
PRV-6527
Crohn's Disease
PRV-300
ulcerative colitis
Johnson & Johnson shows off under-pressure Stelara's latest indication—Crohn's—in new DTC spot
Fierce Pharma
Wed, 08/2/17 - 11:30 am
JNJ
Stelara
Crohn's Disease
drug advertising
DTC ads
Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug
Fierce Biotech
Tue, 05/30/17 - 06:20 pm
JNJ
Protagonist Therapeutics
M&A
Crohn's Disease
PTG-200
AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
BioPharma Dive
Thu, 05/11/17 - 11:17 am
AbbVie
JAK inhibitors
Crohn's Disease
Upadacitinib
Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug
Xtalks
Mon, 02/27/17 - 10:02 pm
Pfizer
Celltrion
biosimilars
Crohn's Disease
Inflectra
Remicade
Takeda, TiGenix stem cell therapy shows sustained effect
Fierce Biotech
Sun, 02/19/17 - 12:16 pm
Takeda
TiGenix
stem cells
Cx601
Crohn's Disease
Gilead Takes Lead on Crohn's over AbbVie
Investopedia
Mon, 11/28/16 - 11:33 pm
Gilead Sciences
AbbVie
Crohn's Disease
Galapagos
filgotinib
ABT-494
Celgene Skips the Placebo, Fails Drug Development 101
TheStreet.com
Wed, 10/19/16 - 10:51 am
Celgene
drug development
clinical trials
placebo
GED-0301
Crohn's Disease
Celgene Crohn's Pill Data Unspectacular but Perhaps Good Enough
TheStreet.com
Mon, 10/17/16 - 11:39 am
Celgene
Crohn's Disease
GED-0301
Could J&J's recent news about its rheumatoid arthritis and Crohn's disease drugs threaten AbbVie's Humira?
Motley Fool
Thu, 10/13/16 - 11:18 am
JNJ
rheumatoid arthritis
Crohn's Disease
AbbVie
Humira
sirukumab
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Endpoints
Mon, 10/3/16 - 10:09 am
AstraZeneca
Amgen
Allergan
MEDI2070
ulcerative colitis
Crohn's Disease

Pages